Introduction: Most children with adrenocortical tumors (ACTs) present with accelerated growth and skeletal maturation at diagnosis, which potentially compromises their adult heights (AHs). Knowledge about growth and pubertal patterns after ACT resection is scarce. This study presents the pubertal and auxological development of patients treated for ACT and followed up at a single pediatric endocrinology service in Brazil. Methods: Retrospective cohort study including 63 patients (47 girls) followed up between 1966 and 2021. Pubertal and auxological data from ACT diagnosis to AH were analyzed. Results: At diagnosis, the patients had median values of bone age (BA) more advanced than chronological age (CA), height standard deviation score greater than target height (TH-SDS), and predicted adult height (PAH-SDS) lower than TH-SDS. The difference between BA and CA decreased gradually during follow-up and the PAH-SDS moved closer to the TH-SDS 7 years after tumor resection. Puberty started at a median CA of 9.3 (8.3–11.3) years in girls and 9.9 (9.2–13.6) years in boys. Nine patients (6 girls) developed central precocious puberty (CPP), which was influenced by a CA >4 years at diagnosis. The difference between AH-SDS and TH-SDS was not significant (p = 0.3). The factors independently associated with AH below TH were CA >4 years at diagnosis, time between clinical manifestation and diagnosis >1 year, and development of CPP. Conclusion: Most patients treated for ACT during childhood attained AH within the TH despite presenting with advanced skeletal maturation at diagnosis. Development of CPP was not infrequent.

Most children with adrenocortical tumors (ACTs) present androgens excess at diagnosis, which cause virilization and acceleration of growth and skeletal maturation. In this manner, the children have tall stature at diagnosis but a potential comprise of their adult heights (AHs). This study reviewed pubertal and growth data from ACT diagnosis to AH of 63 patients followed up in a single pediatric endocrinology service in Brazil in the last 50 years. At diagnosis, the patients of this study had height greater than that would be expected considering their parents heights (target height), but with an estimate to be shorter than their parents as adults, based on their advanced skeletal maturation. During the follow-up, the skeletal maturation gradually became adequate to the chronological age and the majority of the patients attained AH adequate for their target height (TH). Older age at diagnosis (>4 years), longer time between clinical manifestation and diagnosis, and precocious puberty were factors that impacted in AH below target height. Nine of 51 patients evaluated developed precocious puberty, which was not an infrequent finding.

1.
Sandrini
R
,
Ribeiro
RC
,
DeLacerda
L
.
Childhood adrenocortical tumors
.
J Clin Endocrinol Metab
.
1997
;
82
(
7
):
2027
31
.
2.
Ribeiro
RC
,
Pinto
EM
,
Zambetti
GP
,
Rodriguez-Galindo
C
.
The International Pediatric Adrenocortical Tumor Registry initiative: contributions to clinical, biological, and treatment advances in pediatric adrenocortical tumors
.
Mol Cell Endocrinol
.
2012
;
351
(
1
):
37
43
.
3.
Pereira
RM
,
Michalkiewicz
E
,
Sandrini
F
,
Figueiredo
BC
,
Pianovski
M
,
França
SN
, et al
.
Tumores do córtex adrenal na infância
.
Arq Bras Endocrinol Metab
.
2004
;
48
(
5
):
651
8
.
4.
Marques-Pereira
R
,
Delacerda
L
,
Lacerda
HM
,
Michalkiewicz
E
,
Sandrini
F
,
Sandrini
R
.
Childhood adrenocortical tumours: a review
.
Hered Cancer Clin Pr
.
2006
;
4
(
2
):
81
9
.
5.
Pianovski
MA
,
Maluf
EM
,
de Carvalho
DS
,
Ribeiro
RC
,
Rodriguez-Galindo
C
,
Boffetta
P
, et al
.
Mortality rate of adrenocortical tumors in children under 15 years of age in Curitiba, Brazil
.
Pediatr Blood Cancer
.
2006
;
47
(
1
):
56
60
.
6.
Ribeiro
RC
,
Sandrini
F
,
Figueiredo
B
,
Zambetti
GP
,
Michalkiewicz
E
,
Lafferty
AR
, et al
.
An inherited p53 mutation that contributes in a tissue-specific manner to pediatric adrenal cortical carcinoma
.
Proc Natl Acad Sci U S A
.
2001
;
98
(
16
):
9330
5
.
7.
Latronico
AC
,
Pinto
EM
,
Domenice
S
,
Fragoso
MC
,
Martin
RM
,
Zerbini
MC
, et al
.
An inherited mutation outside the highly conserved DNA-binding domain of the p53 tumor suppressor protein in children and adults with sporadic adrenocortical tumors
.
J Clin Endocrinol Metab
.
2001
;
86
(
10
):
4970
3
.
8.
Mastellaro
MJ
,
Ribeiro
RC
,
Oliveira-Filho
AG
,
Seidinger
AL
,
Cardinalli
IA
,
Miranda
ECM
, et al
.
Adrenocortical tumors associated with the TP53 p.R337H germline mutation can be identified during child-care consultations
.
J Pediatr
.
2018
;
94
(
4
):
432
9
.
9.
Costa
TEJ
,
Gerber
VKQ
,
Ibañez
HC
,
Melanda
VS
,
Parise
IZS
,
Watanabe
FM
, et al
.
Penetrance of the TP53 R337H mutation and pediatric adrenocortical carcinoma incidence associated with environmental influences in a 12-year observational cohort in southern Brazil
.
Cancers Basel
.
2019
;
11
(
11
):
1804
.
10.
Garritano
S
,
Gemignani
F
,
Voegele
C
,
Nguyen-Dumont
T
,
Le Calvez-Kelm
F
,
De Silva
D
, et al
.
Determining the effectiveness of high resolution melting analysis for SNP genotyping and mutation scanning at the TP53 locus
.
BMC Genet
.
2009
;
10
:
5
.
11.
Giacomazzi
J
,
Selistre
SG
,
Rossi
C
,
Alemar
B
,
Santos-Silva
P
,
Pereira
FS
, et al
.
Li-Fraumeni and Li-Fraumeni-like syndrome among children diagnosed with pediatric cancer in Southern Brazil
.
Cancer
.
2013
;
119
(
24
):
4341
9
.
12.
Pinto
EM
,
Billerbeck
AE
,
Villares
MC
,
Domenice
S
,
Mendonça
BB
,
Latronico
AC
.
Founder effect for the highly prevalent R337H mutation of tumor suppressor p53 in Brazilian patients with adrenocortical tumors
.
Arq Bras Endocrinol Metab
.
2004
;
48
(
5
):
647
50
.
13.
Riedmeier
M
,
Decarolis
B
,
Haubitz
I
,
Müller
S
,
Uttinger
K
,
Börner
K
, et al
.
Adrenocortical carcinoma in childhood: a systematic review
.
Cancers
.
2021
;
13
(
21
):
5266
.
14.
Gupta
N
,
Rivera
M
,
Novotny
P
,
Rodriguez
V
,
Bancos
I
,
Lteif
A
.
Adrenocortical carcinoma in children: a clinicopathological analysis of 41 patients at the Mayo Clinic from 1950 to 2017
.
Horm Res Paediatr
.
2018
;
90
(
1
):
8
18
.
15.
Kerkhofs
TM
,
Ettaieb
MH
,
Verhoeven
RH
,
Kaspers
GJ
,
Tissing
WJ
,
Loeffen
J
, et al
.
Adrenocortical carcinoma in children: first population-based clinicopathological study with long-term follow-up
.
Oncol Rep
.
2014
;
32
(
6
):
2836
44
.
16.
Ardicli
B
,
User
IR
,
Ciftci
AO
,
Akyuz
C
,
Kutluk
MT
,
Yalcin
B
, et al
.
Adrenocortical tumours in children: a review of surgical management at a tertiary care centre
.
ANZ J Surg
.
2021
;
91
(
5
):
992
9
.
17.
Michalkiewicz
E
,
Sandrini
R
,
Figueiredo
B
,
Miranda
ECM
,
Caran
E
,
Oliveira-Filho
AG
, et al
.
Clinical and outcome characteristics of children with adrenocortical tumors: a report from the international pediatric adrenocortical tumor registry
.
J Clin Oncol
.
2004
;
22
(
5
):
838
45
.
18.
Schmit-Lobe
MC
,
De Lacerda
L
,
Ribeiro
R
,
Kohara
SK
,
Sandrini
R
.
Patterns of growth and development in 26 children operated for adrenocortical carcinoma (ACC) and disease-free for more than one year
.
Pediatr Res
.
1995
;
38
(
4
):
622
.
19.
Schmitt-Lobe
MC
,
Marques-Pereira
R
,
Nesi-França
S
,
Boguszewski
M
,
Lacerda Filho
L
,
Sandrini
R
.
Final Height (FH) of 31 patients who had adrenocortical tumor in the zero to 14 y of age period. Comparison with predicted adult height (PAH) and target height (TH)
.
Horm Res
.
2005
;
64
:
240
.
20.
Hauffa
BP
,
Roll
C
,
Mühlenberg
R
,
Havers
W
.
Growth in children with adrenocortical tumors
.
Klin Padiatr
.
1991
;
203
(
2
):
83
7
.
21.
Salt
AT
,
Savage
MO
,
Grant
DB
.
Growth patterns after surgery for virilising adrenocortical adenoma
.
Arch Child
.
1992
;
67
(
2
):
234
6
.
22.
Valerio
G
,
Spagnuolo
MI
,
Muzzi
G
,
Buono
P
,
Lombardi
F
,
Palmieri
R
, et al
.
Adrenocortical tumor in a boy: final height is not impaired despite a severe advancement of bone age
.
J Pediatr Endocrinol Metab
.
2003
;
16
(
7
):
1061
3
.
23.
Breidbart
E
,
Cameo
T
,
Garvin
JH
,
Hibshoosh
H
,
Oberfield
SE
.
Pubertal outcome in a female with virilizing adrenocortical carcinoma
.
J Pediatr Endocrinol Metab
.
2016
;
29
(
4
):
503
9
.
24.
Stecchini
MF
,
Braid
Z
,
More
CB
,
Aragon
DC
,
Castro
M
,
Moreira
AC
, et al
.
Gonadotropin-dependent pubertal disorders are common in patients with virilizing adrenocortical tumors in childhood
.
Endocr Connect
.
2019
;
8
(
5
):
579
89
.
25.
LoGiurato
D
,
Antal
Z
,
Zhou
P
.
Long-term follow up and treatment outcomes of a 2 year-old-boy with metastatic testosterone-secreting adrenocortical carcinoma
.
AACE Clin Case Rep
.
2020
;
6
(
6
):
e300
4
.
26.
Brito
VN
,
Spinola-Castro
AM
,
Kochi
C
,
Kopacek
C
,
Silva
PC
,
Guerra-Júnior
G
.
Central precocious puberty: revisiting the diagnosis and therapeutic management
.
Arch Endocrinol Metab
.
2016
;
60
(
2
):
163
72
.
27.
Latronico
AC
,
Brito
VN
,
Carel
JC
.
Causes, diagnosis, and treatment of central precocious puberty
.
Lancet Diabetes Endocrinol
.
2016
;
4
(
3
):
265
74
.
28.
Ersoy
B
,
Kizilay
D
,
Cayirli
H
,
Temiz
P
,
Gunsar
C
.
Central precocious puberty secondary to adrenocortical adenoma in a female child: case report and review of the literature
.
J Pediatr Adolesc Gynecol
.
2017
;
30
(
5
):
591
4
.
29.
Oddie
PD
,
Albert
BB
,
Hofman
PL
,
Jefferies
C
,
Laughton
S
,
Carter
PJ
.
Mitotane in the treatment of childhood adrenocortical carcinoma: a potent endocrine disruptor
.
Endocrinol Diabetes Metab Case Rep
.
2018
;
2018
:
18-0059
.
30.
de Onis
M
,
Onyango
AW
,
Borghi
E
,
Siyam
A
,
Nishida
C
,
Siekmann
J
.
Development of a WHO growth reference for school-aged children and adolescents
.
Bull World Health Organ
.
2007
;
85
(
9
):
660
7
.
31.
de Onis
M
,
Garza
C
,
Onyango
AW
,
Rolland-Cachera
MF
;
le Comité de nutrition de la Société française de pédiatrie
.
[WHO growth standards for infants and young children]
.
Arch Pediatr
.
2009
;
16
(
1
):
47
53
.
32.
Marshall
WA
,
Tanner
JM
.
Variations in pattern of pubertal changes in girls
.
Arch Child
.
1969
;
44
(
235
):
291
303
.
33.
Marshall
WA
,
Tanner
JM
.
Variations in the pattern of pubertal changes in boys
.
Arch Child
.
1970
;
45
(
239
):
13
23
.
34.
Partsch
C-J
,
Heger
S
,
Sippell
WG
.
Management and outcome of central precocious puberty
.
Clin Endocrinol
.
2002
;
56
(
2
):
129
48
.
35.
Bayley
N
,
Pinneau
SR
.
Tables for predicting adult height from skeletal age: revised for use with the Greulich-Pyle hand standards
.
J Pediatr
.
1952
;
40
(
4
):
423
41
.
36.
Tanner
JM
.
Use and abuse of growth standards
. In:
Falkner
F
,
Tanner
JM
, editors.
Methodology ecological, genetic, and nutritional effects on growth
.
Boston, MA
:
Springer US
;
1986
. p.
95
109
.
37.
Antonini
SR
,
Leal
LF
,
Cavalcanti
MM
.
Pediatric adrenocortical tumors: diagnosis, management and advancements in the understanding of the genetic basis and therapeutic implications
.
Expert Rev Endocrinol Metab
.
2014
;
9
(
5
):
445
64
.
38.
Nieman
LK
,
Biller
BM
,
Findling
JW
,
Newell-Price
J
,
Savage
MO
,
Stewart
PM
, et al
.
The diagnosis of Cushing’s syndrome: an endocrine society clinical practice guideline
.
J Clin Endocrinol Metab
.
2008
;
93
(
5
):
1526
40
.
39.
Kelly
A
,
Winer
KK
,
Kalkwarf
H
,
Oberfield
SE
,
Lappe
J
,
Gilsanz
V
, et al
.
Age-based reference ranges for annual height velocity in US children
.
J Clin Endocrinol Metab
.
2014
;
99
(
6
):
2104
12
.
40.
Flor-Cisneros
A
,
Leschek
EW
,
Merke
DP
,
Barnes
KM
,
Coco
M
,
Cutler
GB
, et al
.
In boys with abnormal developmental tempo, maturation of the skeleton and the hypothalamic-pituitary-gonadal axis remains synchronous
.
J Clin Endocrinol Metab
.
2004
;
89
(
1
):
236
41
.
41.
Barros
BS
,
Kuschnir
MCMC
,
Bloch
KV
,
Silva
TLND
.
ERICA: age at menarche and its association with nutritional status
.
J Pediatr
.
2019
;
95
(
1
):
106
11
.
42.
Marván
ML
,
Catillo-López
RL
,
Alcalá-Herrera
V
,
Callejo
DD
.
The decreasing age at menarche in Mexico
.
J Pediatr Adolesc Gynecol
.
2016
;
29
(
5
):
454
7
.
43.
Roman
EP
,
Ribeiro
RR
,
Guerra-Júnior
G
,
Barros-Filho
AA
.
Antropometria, maturação sexual e idade da menarca de acordo com o nível socioeconômico de meninas escolares de Cascavel (PR)
.
Rev Assoc Med Bras
.
1992. 2009
;
55
(
3
):
317
21
.
44.
Castilho
SD
,
Nucci
LB
,
Assuino
SR
,
Hansen
LO
.
Importância do viés de memória na obtenção da idade da menarca pelo método recordatório em adolescentes brasileiras
.
Arq Bras Endocrinol Metab
.
2014
;
58
(
4
):
394
7
.
45.
Herman-Giddens
ME
,
Slora
EJ
,
Wasserman
RC
,
Bourdony
CJ
,
Bhapkar
MV
,
Koch
GG
, et al
.
Secondary sexual characteristics and menses in young girls seen in office practice: a study from the Pediatric Research in Office Settings network
.
Pediatrics
.
1997
;
99
(
4
):
505
12
.
46.
Cabrera
SM
,
Bright
GM
,
Frane
JW
,
Blethen
SL
,
Lee
PA
.
Age of thelarche and menarche in contemporary US females: a cross-sectional analysis
.
J Pediatr Endocrinol Metab
.
2014
;
27
(
1–2
):
47
51
.
47.
Nesi-França
S
,
Silveira
RB
,
Rojas Ramos
JCR
,
Cardoso-Demartini
AA
,
Lima Cat
MN
,
de Carvalho
JAR
, et al
.
Pubertal development and adult height in patients with congenital hypothyroidism detected by neonatal screening in southern Brazil
.
J Pediatr Endocrinol Metab
.
2020
;
33
(
11
):
1449
55
.
48.
Mejorado-Molano
FJ
,
Sanz-Calvo
ML
,
Posada-Ayala
A
,
Caballo-Roig
N
,
Gavela-Pérez
T
,
Mahillo-Fernández
I
, et al
.
Adult height in girls with idiopathic premature adrenarche: a cohort study and design of a predictive model
.
Front Endocrinol
.
2022
;
13
:
852422
.
49.
Castilho
SD
,
Saito
MI
,
Barros Filho
ADA
.
Crescimento pós-menarca em uma coorte de meninas brasileiras
.
Arq Bras Endocrinol Metab
.
2005
;
49
(
6
):
971
7
.
50.
Kim
MS
,
Yang
EJ
,
Cho
DH
,
Hwang
PH
,
Lee
DY
.
Virilizing adrenocortical carcinoma advancing to central precocious puberty after surgery
.
Korean J Fam Med
.
2015
;
36
(
3
):
150
3
.
51.
Savaş-Erdeve
Ş
,
Çetinkaya
S
,
Abalı
ZY
,
Poyrazoğlu
Ş
,
Baş
F
,
Berberoğlu
M
, et al
.
Clinical, biochemical and genetic features with nonclassical 21-hydroxylase deficiency and final height
.
J Pediatr Endocrinol Metab
.
2017
;
30
(
7
):
759
66
.
52.
Egli
CA
,
Rosenthal
SM
,
Grumbach
MM
,
Montalvo
JM
,
Gondos
B
.
Pituitary gonadotropin-independent male-limited autosomal dominant sexual precocity in nine generations: familial testotoxicosis
.
J Pediatr
.
1985
;
106
(
1
):
33
40
.
53.
Cunha-Silva
M
,
Brito
VN
,
Macedo
DB
,
Bessa
DS
,
Ramos
CO
,
Lima
LG
, et al
.
Spontaneous fertility in a male patient with testotoxicosis despite suppression of FSH levels
.
Hum Reprod
.
2018
;
33
(
5
):
914
8
.
54.
Menna-Barreto
A
,
Dadalto
JC
,
Pianovski
MAD
,
Uber
M
,
Nesi-França
S
,
Sandrini
R
, et al
.
Abstracts: Peripheral precocious puberty (PPP) in two girls treated with mitotane for adrenocortical carcinoma (ACC)
.
Horm Res Paediatr
.
2010
;
74
(
1
):
15
.
55.
Nader
N
,
Raverot
G
,
Emptoz-Bonneton
A
,
Déchaud
H
,
Bonnay
M
,
Baudin
E
, et al
.
Mitotane has an estrogenic effect on sex hormone-binding globulin and corticosteroid-binding globulin in humans
.
J Clin Endocrinol Metab
.
2006
;
91
(
6
):
2165
70
.
56.
Rossini
E
,
Giacopuzzi
E
,
Gangemi
F
,
Tamburello
M
,
Cosentini
D
,
Abate
A
, et al
.
Estrogen-like effect of mitotane explained by its agonist activity on estrogen receptor-α
.
Biomedicines
.
2021
;
9
(
6
):
681
.
57.
Paul
D
,
Conte
FA
,
Grumbach
MM
,
Kaplan
SL
.
Long-term effect of gonadotropin-releasing hormone agonist therapy on final and near-final height in 26 children with true precocious puberty treated at a median age of less than 5 years
.
J Clin Endocrinol Metab
.
1995
;
80
(
2
):
546
51
.
58.
Klein
KO
,
Barnes
KM
,
Jones
JV
,
Feuillan
PP
,
Cutler
GB
Jr
.
Increased final height in precocious puberty after long-term treatment with LHRH agonists: the National Institutes of Health Experience
.
J Clin Endocrinol Metab
.
2001
;
86
(
10
):
4711
6
.
59.
Lazar
L
,
Padoa
A
,
Phillip
M
.
Growth pattern and final height after cessation of gonadotropin-suppressive therapy in girls with central sexual precocity
.
J Clin Endocrinol Metab
.
2007
;
92
(
9
):
3483
9
.
60.
Vuralli
D
,
Gonc
NE
,
Ozon
ZA
,
Kandemir
N
,
Alikasifoglu
A
.
Which parameters predict the beneficial effect of GnRHa treatment on height in girls with central precocious puberty
.
Clin Endocrinol
.
2021
;
94
(
5
):
804
10
.
You do not currently have access to this content.